Androgen receptor signal acquired oncogenic role in aromatase inhibitor resistant model of breast cancer cell

被引：1
|
作者：
Fujii, R.
Hanamura, T.
Niwa, T.
Yamaguchi, Y.
Ishida, T.
Sasano, H.
Ohuchi, N.
Hayashi, I.
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[2] Shinshu Univ, Grad Sch Med, Matsumoto, Nagano, Japan
[3] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-09-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-10
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bicalutamide Plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer
    Lu, Qianyi
    Xia, Wen
    Lee, Kaping
    Zhang, Jingmin
    Yuan, Huimin
    Yuan, Zhongyu
    Shi, Yanxia
    Wang, Shusen
    Xu, Fei
    ONCOLOGIST, 2020, 25 (01): : 21 - +
  • [22] Upregulation of the androgen agonist prosaposin in aromatase inhibitor resistant breast cancer; mediation by the developmental protein HOXC11
    McIroy, M.
    Hao, Y.
    Bane, F. T.
    Young, L.
    O'Gaora, P.
    CANCER RESEARCH, 2012, 72
  • [23] PI3K pathway as a novel target in androgen-driven aromatase inhibitor resistant breast cancer
    Ali, A.
    Creevey, L.
    Bane, F.
    Marzuki, W. A.
    Hill, A. D. K.
    Young, L. S.
    McIlroy, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S186 - S186
  • [24] PI3K pathway as a novel target in androgen-driven aromatase inhibitor resistant breast cancer
    Ali, A.
    Creevey, L.
    Bane, F.
    Marzuki, W. A.
    Hill, A. D. K.
    Young, L. S.
    McIlroy, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 22 - 22
  • [25] Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
    Lui, Asona
    New, Jacob
    Ogony, Joshua
    Thomas, Sufi
    Lewis-Wambi, Joan
    BMC CANCER, 2016, 16
  • [26] Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
    Asona Lui
    Jacob New
    Joshua Ogony
    Sufi Thomas
    Joan Lewis-Wambi
    BMC Cancer, 16
  • [27] Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
    Swaathi Jayaraman
    Xiaonan Hou
    Mary J. Kuffel
    Vera J. Suman
    Tanya L. Hoskin
    Kathryn E. Reinicke
    David G. Monroe
    Krishna R. Kalari
    Xiaojia Tang
    Megan A. Zeldenrust
    Jingfei Cheng
    Elizabeth S. Bruinsma
    Sarah A. Buhrow
    Renee M. McGovern
    Stephanie L. Safgren
    Chad A. Walden
    Jodi M. Carter
    Joel M. Reid
    James N. Ingle
    Matthew M. Ames
    John R. Hawse
    Matthew P. Goetz
    Breast Cancer Research, 22
  • [28] AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
    Rechoum, Yassine
    Rovito, Daniela
    Iacopetta, Domenico
    Barone, Ines
    Ando, Sebastiano
    Weigel, Nancy L.
    O'Malley, Bert W.
    Brown, Powel H.
    Fuqua, Suzanne A. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (03) : 473 - 485
  • [29] AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
    Yassine Rechoum
    Daniela Rovito
    Domenico Iacopetta
    Ines Barone
    Sebastiano Andò
    Nancy L. Weigel
    Bert W. O’Malley
    Powel H. Brown
    Suzanne A. W. Fuqua
    Breast Cancer Research and Treatment, 2014, 147 : 473 - 485
  • [30] Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
    Kubo, Makoto
    Kanaya, Noriko
    Petrossian, Karineh
    Ye, Jingjing
    Warden, Charles
    Liu, Zheng
    Nishimura, Reiki
    Osako, Tomofumi
    Okido, Masayuki
    Shimada, Kazuo
    Takahashi, Masato
    Chu, Peiguo
    Yuan, Yate-Ching
    Chen, Shiuan
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 93 - 107
12345